Why Corcept Therapeutics Incorporated (CORT) stock fell 7.8% intraday on Wednesday, November 4, 2026

Corcept Therapeutics Incorporated (CORT) traded at $75.52 as of 9:51 AM ET, down 7.83% on Wednesday, November 4, 2026, on volume of 320,970 shares (0.3× its 3-month average); market value about $8.20B.

CORT was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.

What happened: primary sources

Events Nexqual found for CORT on Wednesday, November 4, 2026 or the trading day before (November 3, 2026):

• Nov 3, 2026: Reported Q3 2026 results: EPS $1.01 vs consensus $0.84 (beat), revenue $340.5M vs consensus $336.4M (beat). Guidance: Reiterated 2026 revenue guidance of $1.1 – $1.2 billion. source
• Nov 4, 2026: One of 5 Biotechnology stocks among the day's biggest losers (NRIX, URGN, HRMY, SNDX, CORT), with no comparable group among the biggest gainers

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on CORT

CORT stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: CORT results, November 3, 2026. Other big moves that day: November 4, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:45 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:45 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt